Every person has a network of pain receptors called cannabinoid receptors. They are part of the overall endocannabinoid system. Most of these receptors are located in the central nervous system, including the brain. Cannabis naturally contains substances called cannabinoids. When a person uses cannabis, the cannabinoids enter the body and attach to their cannabinoid receptors, altering their effect. What is the interaction between broad spectrum CBC and the endocannabinoid system? Do they have the potential to treat breast cancer?
CBC and the endocannabinoid system interactions
The endocannabinoid system is affected by broad spectrum cbc in several distinct ways. It first works as a selective CB2 agonist and prevents the inactivation of endocannabinoids.
According to research, phytocannabinoids can enhance health. For example, tetrahydrocannabinol, such as cannabidiol, are phytocannabinoids that lessen pain and enhance overall well-being. In addition, some of these substances are also beneficial for neuroprotection and the reduction of inflammation.
Due to CBC’s ability to connect to cannabinoid receptors in
CBC’s potential for treating breast cancer
The study was conducted in Ontario, Canada, and involved 8 917 187 case patients and 2 654 controls. In addition, case patients and controls were matched to 3 other cases in predefined time intervals. As a result, they had similar demographics, health service use, and comorbidities.
Women with BRCA1/2 mutations are at an increased risk of developing CBC. Therefore, women with these mutations are often offered contralateral preventive mastectomy. However, women with no family history of BC and no genetic mutations are considered to have average risk and are, therefore, not candidates for screening.
The researchers aimed to develop a risk prediction model using a large international series of patient data. The study included 132,756 women with their first primary invasive BC between 1990 and 2013. These women were followed up for a minimum of three years. The researchers then looked at the model’s clinical utility.
In vitro and in vivo studies, CBC inhibits new cancer cells. It may be an effective drug to beat breast cancer when combined with chemotherapy. The research also suggests that CBC may help women with estrogen-positive breast cancer improve their quality of life.
The study compares the risk of invasive CBC versus in situ CBC in patients. Patients with elevated platelet counts had a lower cancer incidence than those with low platelet counts.
Cannabis contains CBC, a substance that engages brain receptors. For example, it binds to the TRPV1 receptor, which regulates inflammatory pain. It also engages the CB2 receptor in interaction. In a study, CBC outperformed CBD oil in terms of its ability to reduce inflammation. The findings prompted researchers to investigate any potential health advantages of CBC.
Although CBC research is still in its infancy, there are encouraging indications that this cannabinoid offers therapeutic advantages. It may have anti-psychotic and mood-stabilizing properties and reduce pain and inflammation. Additional study is necessary to verify these advantages.
The two cannabinoids that have received the most research are CBD and THC, although studies have indicated that CBC may also have significant health advantages. For instance, CBC can help with pain management, mood enhancement, and skin health promotion. Unfortunately, there are only a few CBC research studies, most of which use animals. They do, though, exhibit potential and demand more research. If you’re thinking about trying it, choose a brand of CBC oil that has undergone independent lab testing.
When CBC interacts with the brain’s CB1 cannabinoid receptors, it does not produce a “high” like THC. Instead, it binds to immune system vanilloid receptors, which are involved in the sense of pain and the inflammatory response. Additionally, it benefits brain stem and progenitor cells.